323 related articles for article (PubMed ID: 15028438)
1. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
[TBL] [Abstract][Full Text] [Related]
2. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
3. Urologic diseases in America project: urinary incontinence in males--demographics and economic burden.
Stothers L; Thom D; Calhoun E
J Urol; 2005 Apr; 173(4):1302-8. PubMed ID: 15758786
[TBL] [Abstract][Full Text] [Related]
4. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
5. The total economic burden of overactive bladder in the United States: a disease-specific approach.
Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
[TBL] [Abstract][Full Text] [Related]
6. Health-related consequences of overactive bladder: an economic perspective.
Hu TW; Wagner TH
BJU Int; 2005 Sep; 96 Suppl 1():43-5. PubMed ID: 16086679
[TBL] [Abstract][Full Text] [Related]
7. Economic costs of overactive bladder in the United States.
Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
[TBL] [Abstract][Full Text] [Related]
9. Defining overactive bladder: epidemiology and burden of disease.
Tubaro A
Urology; 2004 Dec; 64(6 Suppl 1):2-6. PubMed ID: 15621220
[TBL] [Abstract][Full Text] [Related]
10. Estimated economic costs of overactive bladder in the United States.
Hu TW; Wagner TH; Bentkover JD; LeBlanc K; Piancentini A; Stewart WF; Corey R; Zhou SZ; Hunt TL
Urology; 2003 Jun; 61(6):1123-8. PubMed ID: 12809878
[TBL] [Abstract][Full Text] [Related]
11. The economic costs of overactive bladder in Germany.
Klotz T; Brüggenjürgen B; Burkart M; Resch A
Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
[TBL] [Abstract][Full Text] [Related]
12. The current and future burden and cost of overactive bladder in five European countries.
Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
[TBL] [Abstract][Full Text] [Related]
13. Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data.
Hall JA; Nelson MA; Meyer JW; Williamson T; Wagner S
Manag Care Interface; 2001 Aug; 14(8):69-75. PubMed ID: 11517841
[TBL] [Abstract][Full Text] [Related]
14. Lower urinary tract symptoms in women.
Milsom I
Curr Opin Urol; 2009 Jul; 19(4):337-41. PubMed ID: 19444118
[TBL] [Abstract][Full Text] [Related]
15. Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact.
Thom DH; Nygaard IE; Calhoun EA
J Urol; 2005 Apr; 173(4):1295-301. PubMed ID: 15758785
[TBL] [Abstract][Full Text] [Related]
16. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
[TBL] [Abstract][Full Text] [Related]
17. The wet patient: understanding patients with overactive bladder and incontinence.
Serels S
Curr Med Res Opin; 2004 Jun; 20(6):791-801. PubMed ID: 15200735
[TBL] [Abstract][Full Text] [Related]
18. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
[TBL] [Abstract][Full Text] [Related]
19. Economic considerations in overactive bladder.
Hu TW; Wagner TH
Am J Manag Care; 2000 Jul; 6(11 Suppl):S591-8. PubMed ID: 11183902
[TBL] [Abstract][Full Text] [Related]
20. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.
Irwin DE; Kopp ZS; Agatep B; Milsom I; Abrams P
BJU Int; 2011 Oct; 108(7):1132-8. PubMed ID: 21231991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
